What does CUSIP 253748305 represent in this 13F holders report?

CUSIP 253748305 is the security identifier for 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR used to aggregate holder disclosures.

How many institutions held 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in Q2 2022?

No institutional holders were reported for 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in Q2 2022; review adjacent reporting periods for trend context.

DIFFUSION PHARMACEUTICALS IN - COM PAR

CUSIP: 253748305

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / COM PAR
Total 13F shares: 0
Share change: -8,958,103
Total reported value: $0
Number of holders: 0
Value change: -$2,343,000
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 253748305?
CUSIP 253748305 identifies 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q1 2022

Recent filing periods for CUSIP 253748305:

Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020

DIFFUSION PHARMACEUTICALS IN - COM PAR

Q2 2022 13F Holders as of 30 Jun 2022

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of DIFFUSION PHARMACEUTICALS IN - COM PAR as of Q2 2022.